Skip to main content
. 2021 Sep 3;43(5):2205–2213. doi: 10.1007/s11357-021-00452-9

Table 1.

Demographic and clinical characteristics of adult COVID-19 patients included in the study, grouped by favipiravir exposure

graphic file with name 11357_2021_452_Tab1_HTML.jpg

n.a., not applicableaPer the World Health Organization criteriabFrom first positive respiratory SARS-CoV-2 PCR sample